The Great Beyond: More big pharma moves in the cannabis arena
http://blogs.nature.com/news/thegreatbeyond/2011/04/more_big_pharma_moves_in_the_c.html (The Great Beyond - Blog Posts)
Novartis is paying out at least $5 million to get into the cannabinoid arena by linking up with UK company GW Pharmaceuticals.
assurance de “political moves”... certains vont avoir du mal à se renier.
“One analyst told the FT he would predict a market of $100m for annual sales for MS spasticity in Europe and Canada. But some reports put the size of the quasi-legal medical marijuana market at over a billion dollars, incentive enough for big companies like Novartis to get a foot in the door early.”
A commencer par ce “one analyst [who] told the FT”